C000218208 Holdings — JNL/Mellon Healthcare Sector Fund
All 135 reported holdings of JNL/Mellon Healthcare Sector Fund (C000218208) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly and Company | 12.30% | $313.78M |
| Johnson & Johnson | 9.88% | $252.18M |
| AbbVie Inc. | 6.45% | $164.56M |
| Merck & Co., Inc. | 5.01% | $127.95M |
| UnitedHealth Group Incorporated | 4.12% | $105.09M |
| Amgen Inc. | 3.18% | $81.05M |
| Thermo Fisher Scientific Inc. | 3.10% | $79.14M |
| Abbott Laboratories | 3.00% | $76.50M |
| Gilead Sciences, Inc. | 2.90% | $74.10M |
| Intuitive Surgical, Inc. | 2.73% | $69.68M |
| Pfizer Inc. | 2.67% | $68.20M |
| Bristol-Myers Squibb Company | 2.07% | $52.89M |
| Danaher Corporation | 2.05% | $52.34M |
| Stryker Corporation | 1.99% | $50.89M |
| Vertex Pharmaceuticals Incorporated | 1.90% | $48.51M |
| Medtronic, Inc. | 1.87% | $47.63M |
| McKesson Corporation | 1.79% | $45.77M |
| Boston Scientific Corporation | 1.56% | $39.75M |
| CVS Health Corporation | 1.52% | $38.90M |
| Regeneron Pharmaceuticals, Inc. | 1.31% | $33.34M |
| HCA Healthcare, Inc. | 1.29% | $32.86M |
| Cigna Group, The | 1.18% | $30.00M |
| Elevance Health, Inc. | 1.09% | $27.83M |
| Cencora, Inc. | 0.97% | $24.64M |
| Cardinal Health, Inc. | 0.85% | $21.59M |
| Zoetis Inc. | 0.84% | $21.53M |
| Edwards Lifesciences Corporation | 0.77% | $19.76M |
| Becton, Dickinson and Company | 0.76% | $19.32M |
| IDEXX Laboratories, Inc. | 0.72% | $18.46M |
| Alnylam Pharmaceuticals, Inc. | 0.71% | $18.02M |
| Insmed Incorporated | 0.57% | $14.63M |
| ResMed Inc. | 0.56% | $14.16M |
| Agilent Technologies, Inc. | 0.55% | $13.91M |
| GE HealthCare Technologies Inc. | 0.54% | $13.86M |
| Waters Corporation | 0.49% | $12.49M |
| IQVIA Holdings Inc | 0.48% | $12.35M |
| Natera, Inc. | 0.45% | $11.56M |
| Veeva Systems Inc. | 0.44% | $11.30M |
| JNL Government Money Market Fund | 0.44% | $11.28M |
| Biogen Inc. | 0.44% | $11.13M |
| Mettler-Toledo International Inc. | 0.43% | $10.96M |
| DexCom, Inc. | 0.41% | $10.52M |
| United Therapeutics Corporation | 0.40% | $10.09M |
| Labcorp Holdings Inc. | 0.38% | $9.58M |
| Quest Diagnostics Incorporated | 0.37% | $9.33M |
| Steris Public Limited Company | 0.35% | $8.99M |
| Humana Inc. | 0.35% | $8.94M |
| Medline Inc. | 0.32% | $8.28M |
| Illumina, Inc. | 0.32% | $8.06M |
| West Pharmaceutical Services, Inc. | 0.30% | $7.74M |
| Zimmer Biomet Holdings, Inc. | 0.30% | $7.71M |
| Moderna, Inc. | 0.29% | $7.52M |
| Revolution Medicines, Inc. | 0.29% | $7.30M |
| Hologic, Inc. | 0.28% | $7.26M |
| Royalty Pharma PLC | 0.28% | $7.19M |
| Tenet Healthcare Corporation | 0.28% | $7.08M |
| Viatris Inc. | 0.26% | $6.66M |
| Centene Corporation | 0.26% | $6.60M |
| Incyte Corporation | 0.25% | $6.49M |
| Insulet Corporation | 0.25% | $6.29M |
| Cooper Companies, Inc., The | 0.24% | $6.03M |
| Neurocrine Biosciences, Inc. | 0.22% | $5.59M |
| Penumbra, Inc. | 0.21% | $5.26M |
| Align Technology, Inc. | 0.21% | $5.24M |
| Guardant Health, Inc. | 0.19% | $4.97M |
| Ensign Group, Inc., The | 0.19% | $4.96M |
| Elanco Animal Health Incorporated | 0.19% | $4.86M |
| Jazz Pharmaceuticals Public Limited Company | 0.19% | $4.81M |
| Ionis Pharmaceuticals, Inc. | 0.19% | $4.75M |
| Medpace Holdings, Inc. | 0.18% | $4.67M |
| Roivant Sciences Ltd. | 0.18% | $4.62M |
| Exelixis, Inc. | 0.18% | $4.62M |
| BioMarin Pharmaceutical Inc. | 0.18% | $4.61M |
| Bridgebio Pharma, Inc. | 0.17% | $4.44M |
| Globus Medical, Inc. | 0.17% | $4.28M |
| Revvity, Inc. | 0.17% | $4.25M |
| Canticle Pharmaceuticals, Inc. | 0.16% | $4.14M |
| Universal Health Services, Inc. | 0.16% | $4.08M |
| Encompass Health Corporation | 0.16% | $3.96M |
| Solventum Corporation | 0.15% | $3.85M |
| Baxter International Inc. | 0.14% | $3.66M |
| Masimo Corporation | 0.14% | $3.57M |
| Bio-Techne Corporation | 0.14% | $3.57M |
| AptarGroup, Inc. | 0.14% | $3.54M |
| Halozyme Therapeutics, Inc. | 0.13% | $3.44M |
| Charles River Laboratories International, Inc. | 0.13% | $3.35M |
| Henry Schein, Inc. | 0.13% | $3.33M |
| Cytokinetics, Incorporated | 0.13% | $3.29M |
| Arrowhead Pharmaceuticals Inc | 0.13% | $3.21M |
| Vaxcyte, Inc. | 0.12% | $3.18M |
| Praxis Precision Medicines, Inc. | 0.12% | $3.08M |
| HealthEquity, Inc. | 0.12% | $3.04M |
| Molina Healthcare, Inc. | 0.11% | $2.90M |
| Krystal Biotech, Inc. | 0.11% | $2.83M |
| Axsome Therapeutics, Inc. | 0.11% | $2.82M |
| Repligen Corporation | 0.11% | $2.70M |
| Glaukos Corporation | 0.09% | $2.42M |
| Teleflex Incorporated | 0.09% | $2.39M |
| Chemed Corporation | 0.09% | $2.37M |
| Alkermes Public Limited Company | 0.09% | $2.36M |
| Protagonist Therapeutics, Inc. | 0.09% | $2.36M |
| Bio-Rad Laboratories, Inc. | 0.09% | $2.34M |
| Davita Inc. | 0.09% | $2.33M |
| Avantor, Inc. | 0.09% | $2.29M |
| Lantheus Holdings, Inc. | 0.09% | $2.23M |
| TG Therapeutics, Inc. | 0.08% | $2.08M |
| PTC Therapeutics, Inc. | 0.08% | $2.04M |
| Rhythm Pharmaceuticals, Inc. | 0.08% | $1.97M |
| Nuvalent, Inc. | 0.08% | $1.94M |
| Kymera Therapeutics, Inc. | 0.08% | $1.92M |
| CRISPR Therapeutics AG | 0.07% | $1.91M |
| Option Care Health, Inc. | 0.07% | $1.87M |
| Arcellx Inc. | 0.07% | $1.86M |
| Hims & Hers Health, Inc. | 0.07% | $1.83M |
| Merit Medical Systems, Inc. | 0.07% | $1.76M |
| Corcept Therapeutics Incorporated | 0.07% | $1.66M |
| Tempus AI, Inc. | 0.06% | $1.65M |
| Irhythm Holdings, Inc. | 0.06% | $1.58M |
| Bruker Corporation | 0.06% | $1.58M |
| RadNet, Inc. | 0.06% | $1.58M |
| Crinetics Pharmaceuticals, Inc. | 0.06% | $1.58M |
| Viking Therapeutics, Inc. | 0.06% | $1.47M |
| TransMedics Group, Inc. | 0.05% | $1.32M |
| Doximity, Inc. | 0.05% | $1.32M |
| Brightspring Health Services, Inc. | 0.05% | $1.22M |
| Jackson National Asset Management, LLC | 0.04% | $937.45K |
| Sotera Health LLC | 0.04% | $909.34K |
| ADMA Biologics, Inc. | 0.04% | $894.81K |
| Summit Therapeutics Inc. | 0.03% | $890.12K |
| Alignment Healthcare, Inc. | 0.03% | $840.37K |
| Waystar Holding Corp. | 0.03% | $797.90K |
| Soleno Therapeutics, Inc. | 0.02% | $635.58K |
| uniQure N.V. | 0.01% | $379.35K |
| Chicago Mercantile Exchange | 0.00% | $19.53K |
| Akero Therapeutics Inc. | 0.00% | $18.84K |
C000218208 overview: performance, fees, allocation and SEC filings